Who Owns Aevis Victoria Company?

GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Aevis Victoria

Full Company Analysis:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who owns Aevis Victoria?

The strategic shift in early 2025 saw Aevis Victoria pivot to an asset-light investment model, with institutional partners increasing stakes in its medical arm. Founded in 2006 as Genolier Swiss Medical Network and based in Fribourg, the group now spans healthcare, luxury hospitality, and real estate.

Who Owns Aevis Victoria Company?

Ownership is concentrated among a core of majority shareholders and institutional investors, providing stability for long-term capital deployment across its three pillars. Explore more via Aevis Victoria Porter's Five Forces Analysis.

Who Founded Aevis Victoria?

Founders and Early Ownership of AEVIS VICTORIA trace to Antoine Hubert, who entered healthcare by acquiring Clinique de Genolier in 2002 and established AEVIS Holding SA in 2006 to scale private clinics across Switzerland.

Icon

Founder: Antoine Hubert

Hubert transitioned from real estate and finance to healthcare, buying Clinique de Genolier in 2002 and building a platform for expansion.

Icon

Formation of Holding

AEVIS Holding SA was created in 2006 as the vehicle for national roll-out and consolidation of private clinics.

Icon

Strategic Partner: Michel Reybier

Reybier joined as a major strategic investor, bringing capital and hospitality-industry experience to support growth.

Icon

Early Capital Base

Initial funding came from Hubert’s investment entities and a network of Swiss private investors and family offices.

Icon

Ownership Philosophy

Early agreements emphasized long-term control and reinvestment, limiting dividend extraction to support scaling.

Icon

Acquisition Strategy

Hubert and Reybier used personal capital and credit facilities to acquire distressed or family-owned clinics, expanding nationwide within a decade.

Early ownership concentrated control with the founders and close investors, establishing a corporate structure that prioritized operational stability and reinvestment over short-term returns; see Mission, Vision & Core Values of Aevis Victoria for related context: Mission, Vision & Core Values of Aevis Victoria

Icon

Key early ownership facts

Founding period metrics and structural points reflecting Aevis Victoria ownership and ownership history.

  • Founding year of platform expansion: 2006 with AEVIS Holding SA formation
  • Initial major asset acquisition: Clinique de Genolier in 2002
  • Ownership concentrated among founder entities and family offices; majority control retained by founder-led groups
  • Corporate headquarters established in Switzerland to centralize Aevis Victoria corporate structure and operations

Complete Aevis Victoria Strategy Bundle

  • 6 Full Frameworks, 1 Company – All Pre-Researched
  • Each Framework Fully Sourced with Real Company Data
  • Built for Strategy Courses, Case Studies & MBA Programs
  • Adapt to Your Assignment – No Starting from Scratch
  • 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
Get Related Template

How Has Aevis Victoria’s Ownership Changed Over Time?

Aevis Victoria’s ownership transformed after its 2006 SIX listing, enabling major acquisitions and the 2014–2015 merger with Victoria-Jungfrau that added luxury hospitality to the group; by early 2025 ownership is highly consolidated under a dominant strategic investor. Key transactions and targeted divestments have since reshaped the capital base and governance.

Year / Event Ownership Impact Notes
2006 — IPO on SIX Introduced public free float Provided liquidity for M&A and expansion
2014–2015 — Merger with Victoria-Jungfrau Integrated luxury hospitality Shifted group strategy toward hotels and real estate
2025 — Major consolidation 76.5% held by M.R.S.I. M.R.S.I. controlled by Antoine Hubert and Michel Reybier

By early 2025 the free float on the SIX Swiss Exchange is approximately 18.2%, while subsidiary-level investors include insurers and institutions that took stakes in operating entities rather than the parent holding.

Icon

Major stakeholders and milestones

The current ownership structure centers on a controlling holding, plus targeted institutional stakes at subsidiary level that link payers and providers.

  • M.R.S.I. Medical Research, Services and Investments S.A. — 76.5% of share capital and voting rights
  • Visana Beteiligungen AG — 11.1% stake in Swiss Medical Network (subsidiary)
  • Free float on SIX — ~18.2% comprising retail, mutual funds and pension funds
  • Post-IPO strategy: divestments of minority operating stakes to fund real estate development

For further context on the group’s market positioning and target segments, see Target Market of Aevis Victoria

From PESTLE Factors to Full Strategy Bundle

  • PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
  • Every Strategic Angle Covered – Nothing Left to Research
  • Pre-filled with Company-Specific Research
  • No Missing Sections for Your Case Study
  • One Download Covers Your Entire Company Analysis
Get Related Template

Who Sits on Aevis Victoria’s Board?

The current Board of Directors of AEVIS VICTORIA SA is compact and aligned with its concentrated ownership; Christian Wenger chairs the board, Raymond Loretan is Vice-Chairman, and the Delegate of the Board is Antoine Hubert, while Michel Reybier also represents the majority shareholder M.R.S.I. S.A.

Director Role Representative/Expertise
Christian Wenger Chairman Swiss legal expert (venture capital, corporate law)
Raymond Loretan Vice-Chairman Diplomatic and public sector experience
Antoine Hubert Delegate of the Board Represents M.R.S.I. S.A. / executive control
Michel Reybier Director Represents M.R.S.I. S.A. / majority shareholder
Dr. Cédric George Director Clinical expertise; represents medical professionals

Voting follows a one-share-one-vote rule for registered shares with 15,364,525 shares outstanding as of 2025, and M.R.S.I. S.A. holds a controlling 76.5% block, effectively consolidating strategic and operational control.

Icon

Board control and voting balance

The board’s lean composition mirrors Aevis Victoria ownership concentration and reduces the likelihood of external challenges to governance decisions.

  • One-share-one-vote structure applies to registered shares
  • M.R.S.I. S.A. holds 76.5%, blocking activist influence
  • Total shares outstanding: 15,364,525 (2025)
  • Major transactions, including the Infracore spin-off, were executed without proxy battles

For further corporate and governance context on Aevis Victoria shareholders and ownership structure, see the article Marketing Strategy of Aevis Victoria.

Aevis Victoria Business Model + Strategy Bundle

  • Ideal for Essays, Case Studies & Slides
  • Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
  • Company-Specific Content Already Organized
  • One Bundle Replaces Days of Independent Research
  • Buy the Bundle Once. Use Across All Your Assignments
Get Related Template

What Recent Changes Have Shaped Aevis Victoria’s Ownership Landscape?

Between 2022 and 2025 Aevis Victoria ownership shifted toward an asset-light model, with the group reducing consolidated holdings and diluting stakes at subsidiary level to crystallize value and cut debt while retaining operational control.

Year Key change Ownership impact
2022–2023 Launch of asset-light initiatives and minority partnerships Reduced consolidated capital intensity; minority shareholder base expanded
2024 Further dilution in Swiss Medical Network as Visana and physician groups increased equity AEVIS stake moved toward ~80%; consolidated debt lowered
2025 Institutional interest in Michel Reybier Hospitality rose; share buybacks executed Valuation uplift in hospitality; buybacks signalled confidence to minority shareholders

Market commentary in 2025 indicated continued consolidation plans in Swiss private healthcare and potential strategic actions for the real estate division dependent on Swiss property markets, while founders maintained a preference for public listing to enable future capital raises and international expansion; see related analysis in Competitors Landscape of Aevis Victoria.

Icon Stake dilution at subsidiary level

Bringing in strategic minority partners like insurers and physician groups has reduced capital exposure and preserved operational control.

Icon Hospitality valuation trend

Michel Reybier Hospitality saw valuation gains in 2024–25, driven by a post-pandemic luxury travel rebound and rising institutional interest.

Icon Shareholder actions

Share buybacks in 2025 were used to absorb excess liquidity and signal confidence to Aevis Victoria shareholders and minority investors.

Icon Outlook for 2026

Expect continued consolidation in Swiss private healthcare, possible separate listing or partial privatization of real estate if Swiss property conditions remain favorable.

From Five Forces to Full Company Analysis

  • Includes SWOT, PESTLE, BMC, BCG and 4P's
  • Pre-Researched with Company-Specific Data
  • Best Value for a Complete Analysis
  • Ready to Adapt for Your Case Study
  • Ready for Essays and Slidesd
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.